Industry

BOSTON–(BUSINESS WIRE)–#PR—Ford Hutman Media (“FHM”) and Pinkergreen today announced Greenford, a new firm to support emerging biotech and life-science companies move from stealth to scale with integrated communications, brand strategy, and website development. The firm was founded by two female industry leaders, Rachel Ford Hutman, Co-Founder of Greenford and Principal at FHM, and Kelley Shaw-Wade, … [Read more…]

— XmAb819 is well-tolerated in heavily pretreated patients with advanced ccRCC — — 25% overall response rate (ORR) observed within the target dose range — — First dose-expansion cohort has been selected; dose escalation continues to identify dose for second expansion cohort — — Management hosting webcast and conference call today at 1:30 p.m. ET … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Dermal Fillers Market by Brand (Juvederm, Sculptra, Radiesse), Product (Hyaluronic, Collagen, PLLA), Procedure (Skin Rejuvenation, Scar Removal, Face & Body Contouring), End User (Dermatology Clinic, Beauty Centers, Medical Spa) – Global Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. The dermal fillers market is expected to experience significant growth, increasing from … [Read more…]

First U.S. Surgical Treatments with PFA Clamp for Patients with Atrial Fibrillation During Concomitant Surgical Procedure HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the enrollment of the first patient in its NANOCLAMP AF Study … [Read more…]

BALTIMORE–(BUSINESS WIRE)–Protaryx Medical, an innovative medical device company developing disruptive access solutions for minimally invasive left-heart procedures, today announced that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its proprietary Transseptal Puncture Device. This submission marks a major milestone in the Company’s mission to redefine safe, efficient … [Read more…]

Significant unmet need for patients requires new and novel treatments1 DREAMM-7 showed a 51% reduction in the risk of death and tripled median progression-free survival in 3L+ indicated population versus a daratumumab-based triplet2 Blenrep is the only anti-BCMA accessible in the community setting where 70% of patients receive care, and with a new streamlined REMS … [Read more…]

DEL MAR, Calif.–(BUSINESS WIRE)–Sydnexis, Inc., (www.sydnexis.com), a biopharmaceutical company focused on pediatric progressive myopia (PPM), today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) for the New Drug Application (NDA) for SYD-101, a proprietary 0.01% atropine formulation developed with enhanced ocular delivery characteristics and room-temperature stability to … [Read more…]

First two monotherapy dose levels (400 mg QD and 600 mg QD) cleared, with no dose-limiting toxicities reported Promising anti-tumor activity observed in patients with various solid tumors, including advanced pancreatic ductal adenocarcinoma No nausea, vomiting, or diarrhea greater than Grade 1 was observed Enrollment initiated for VS-7375 in combination with cetuximab in patients with … [Read more…]

New initiative creates pathways to employment and connection for individuals with intellectual and developmental disabilities across Belmont Village communities. HOUSTON–(BUSINESS WIRE)–Belmont Village Senior Living is excited to announce its national employment partnership with Best Buddies International, a nonprofit organization dedicated to creating opportunities for one-to-one friendships, integrated employment, leadership development, inclusive living, and family support … [Read more…]

Strategically established life sciences air corridor will link Shannon, Ireland, and Wilmington, North Carolina, marking the first fully dedicated, temperature-controlled network of its kind SHANNON, Ireland & WILMINGTON, N.C.–(BUSINESS WIRE)–Frontier Scientific Solutions (“Frontier”) today announced the initial flight schedule for its nonstop, temperature‑controlled air corridor between Shannon Airport (SNN) and Wilmington International Airport (ILM). Developed … [Read more…]